References
- Wald NJ, Rodeck C, Hackshaw AK, et al. First and second trimester antenatal screening for Down’s syndrome: the results of the Serum, Urine and Ultrasound Screening Study SURUSS. J Med Screen 2003;10:56–104
- Nicolaides KH, Spencer K, Avgidou K, et al. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 2005;25:221–6
- Sainz JA, Serrano R, Turmo E, et al. Contribution of “modified genetic sonography” to the combined test as a screening method for chromosomal abnormalities. J Matern Fetal Neonatal Med 2012;25:1399–405
- Programa andaluz de cribado de anomalías congénitas (PACAC). Available from: www.juntadeandalucia.es/servicioandaluzdesalud/publicaciones
- Spanish Society of Obstetrics and Gynaecology. Available from: www.sego.es
- Royal College of Obstetricians and Gynaecologists. Available from: www.rcog.org.uk
- COANh. Sistema de contabilidad de gestión hospitalaria 2011. Servicio Andaluz de Salud. Available from: www.mago.easp.es
- Palomaki GE, Steinort K, Knight GJ, Haddow JE. Comparing three screening strategies for combining first- and second-trimester Down syndrome markers. Obstet Gynecol 2006;107:367–75
- Rozenberg P, Bussieres L, Chevret S, et al. Screening for Down syndrome using first-trimester combined screening followed by second-trimester ultrasound examination in an unselected population. Am J Obstet Gynecol 2006;195:1379–87
- Aagaard-Tillery KM, Malone FD, Nyberg DA, et al. Role of second-trimester genetic sonography after Down Syndrome screening. Obstet Gynecol 2009;114:1189–96
- Wright D, Bradbury I, Benn P, et al. Contingent screening for Down syndrome is an efficient alternative to non-disclosure sequential screening. Prenat Diagn 2004;24:762–6
- Muñoz-Cortes M, Arigita M, Falguera G, et al. Contingent screening for Down síndrome completed in the first trimester. Multicenter study. Ultrasound Obstet Gynecol 2012;39:396–400
- Ramos-Corpas DJ, Santiago JC. Combined test + inhibin A at week 13 in contingent sequential testing: an interesting alternative for first-trimester prenatal screening for Down Syndrome. Prenat Diagn 2008;28:833–8
- Benn PA, Kaminsky LM, Ying J, et al. Combined second-trimester biochemical and ultrasound screening for Down syndrome. Obstet Gynecol 2002;100:1168–76
- Sahota DS, Leung TY, Chan LW, et al. Comparison of firsttrimester contingent screening strategies for Down syndrome. Ultrasound Obstet Gynecol 2010;35:286–91
- Kagan KO, Staboulidou I, Cruz J, et al. Two-stage first-trimester screening for trisomy 21 by ultrasound assessment and biochemical testing. Ultrasound Obstet Gynecol 2010;36:542–7
- NHS fetal anomaly screening programme screening for Down's syndrome: UK NSC policy recommendations 2011-2014 model of best practice. Available from: www.fetalanomaly.screening.nhs.uk
- Sainz JA, Zurita MJ, Borrero C, et al. Role of foetal echocardiography in stepwise sequential screening for chromosomal disorders (combined test associated with modified genetic sonography). J Matern Fetal Neonatal Med. 2012;25:2216–20
- Smith-Bindman R, Hosmer W, Feldstein V, et al. Down Syndrome: a Meta-analysis Second-Trimester Ultrasound to Detect Fetuses With. J Am Med Assoc 2001;285:1044–55
- Wright D, Bradbury I, Cuckle H, et al. Three-stage contingent screening for Down syndrome. Prenat Diagn 2006;26:528–34
- Benn P, Wright D, Cuckle H. Practical strategies in contingent sequential screening for Down syndrome. Prenat Diagn 2005;25:645–52
- Ebrashy A, El Kateb A, Momtaz M, et al. 13–14-Week fetal anatomy scan: a 5-year prospective study. Ultrasound Obstet Gynecol 2010;35:292–6
- Syngelaki A, Chelemen T, Dagklis T, et al. Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11–13 weeks. Prenat Diagn 2011;31:90–102